Skip to main content

Research Repository

Advanced Search

Intra-articular hyaluronic acid injections for hip osteoarthritis: a level I systematic review

Migliorini, Filippo; Pilone, Marco; Mazzoleni, Manuel Giovanni; Schäfer, Luise; Katusic, Dragana; Maffulli, Nicola

Authors

Filippo Migliorini

Marco Pilone

Manuel Giovanni Mazzoleni

Luise Schäfer

Dragana Katusic

Nicola Maffulli



Abstract

Purpose: The present systematic review investigated the efficacy of intra-articular hyaluronic acid (HA) viscosupplementation for hip osteoarthritis (OA) in patient-reported outcome measures (PROMs) and whether different molecular weights of HA are associated with different outcomes. Methods: This study was conducted according to the 2020 PRISMA statement. In January 2025, PubMed, Web of Science, Google Scholar, and Embase were accessed. All the randomised controlled trials (RCTs) evaluating the efficacy of intra-articular HA injections in the hip for OA were included. Results: Nine hundred and eighty-two patients (56% women, mean age 62.2 ± 4.0 years, mean follow-up 6.4 ± 2.7 months, mean BMI 27.5 ± 2.1 kg/m2) were analysed. Patients receiving high molecular weight (HMW) and low molecular weight (LMW) HA showed significant improvements in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and visual analogue scale (VAS) scores (P < 0.05). No significant differences in VAS or WOMAC were observed among groups at 3–4 months of follow-up. However, at 4–6 months, the HMW HA group exhibited significantly lower VAS scores compared to the medium molecular weight (MMW) (mean difference, MD − 1.4, 95% CI − 2.1 to − 0.7, P < 0.0001), placebo (MD − 1.6, 95% CI − 2.1 to − 1.1, P < 0.0001), and control (MD − 1.3, 95% CI − 1.8 to − 0.8, P < 0.0001) groups. WOMAC scores at 4–6 months demonstrated that both HMW and MMW HA performed better than the control group (P < 0.0001), but no significant difference was observed between HMW and MMW (P = 1.0). Conclusion: Intra-articular injections of HA effectively reduce knee OA symptoms. Moreover, HMW HA performs better than MMW HA at a mean of 4–6 months of follow-up. Level of evidence: Level I, systematic review of RCTs.

Citation

Migliorini, F., Pilone, M., Mazzoleni, M. G., Schäfer, L., Katusic, D., & Maffulli, N. (2025). Intra-articular hyaluronic acid injections for hip osteoarthritis: a level I systematic review. European Journal of Orthopaedic Surgery and Traumatology, 35(1), 1-12. https://doi.org/10.1007/s00590-025-04292-7

Journal Article Type Review
Acceptance Date Apr 4, 2025
Online Publication Date May 9, 2025
Publication Date May 9, 2025
Deposit Date May 16, 2025
Publicly Available Date May 16, 2025
Journal European Journal of Orthopaedic Surgery & Traumatology
Print ISSN 1633-8065
Electronic ISSN 1432-1068
Publisher Springer Verlag
Peer Reviewed Peer Reviewed
Volume 35
Issue 1
Article Number 180
Pages 1-12
DOI https://doi.org/10.1007/s00590-025-04292-7
Keywords Hyaluronic acid, Injections, Hip, Osteoarthritis
Public URL https://keele-repository.worktribe.com/output/1232727

Files

Intra-articular hyaluronic acid injections for hip osteoarthritis: a level I systematic review (691 Kb)
Archive

Licence
https://creativecommons.org/licenses/by/4.0/

Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/

Copyright Statement
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.






You might also like



Downloadable Citations